Pre-Clinical Development

Animal studies could lead to blood tests that could guide doctors in better matching drugs to patients based on immune system biomarkers.

/PRNewswire-PRWeb/ -- BioChain, a global provider of biospecimen products and specialty laboratory services, today announced a strategic partnership with...

While main results from a platform study of four experimental drugs for amyotrophic lateral sclerosis are negative, it shows this novel platform trial model works.

Pin-prick blood tests that detect possible precursors of Alzheimer's disease are becoming available – but is it right to label people who will never develop the disease?

A new computational technique allows large language models to predict antibody structures more accurately. The work could enable researchers to sift through millions of possible antibodies to identify those that could be used to treat SARS-CoV-2 and other infectious diseases.

Study results are 'historic,' expert says

/PRNewswire-PRWeb/ -- Ambrosia Biosciences Announces $25MM Series A Financing, Including Strategic Investment by...

About a third of patients with diffuse large B cell lymphoma (DLBCL), a fast-growing form of lymphoma, will see their disease advance or recur following...

The new buprenorphine formulation is used as a substitution treatment in adults and adolescents 15 years or older who agree to be treated for addiction.

Stem cells made in the lab may one day aid cancer treatment by reducing our reliance on donors

Maybe one of your patients is eligible for a new colorectal cancer clinical trial?

Progression to full-blown RA slowed

Patients need to be trained in administering epinephrine to avoid delaying treatment, experts say

Cabozantinib-pembrolizumab induced responses in 16 of 35 evaluable patients, but needed one more

A growing number of studies are showing beneficial clinical effects from noninvasive stimulation of gamma rhythms in the brain, but clinical evidence remains preliminary and animal studies have been instructive, but not definitive.

A retired psychologist attacked an article of mine about deranged Florida Surgeon General Joseph Ladapo's views of public health policies toward the COVID-19 pandemic. His assertions ranged from the preposterous to the merely inaccurate.

The gene therapy developer would provide Novartis access to its RNA-based screening platform — which helps in rapid discovery of experimental gene therapies ...

Adding agent to T-DM1 resulted in 2-month progression-free survival improvement

The first-in-human HEART-1 trial of in vivo DNA editing called VERVE-101, shows reductions in LDL and PCSK9 protein in patients with familial hypercholesterolemia.

The ornithine decarboxylase inhibitor α-difluoromethylornithine, used to treat African sleeping sickness and unwanted hair growth, may also protect β cells of people with new-onset type 1 diabetes.